Two pharmacy students practice compounding medications
WSU College of Pharmacy and Pharmaceutical Sciences

Impact Report

2025

New Leaders. Shared Vision.

2025-2026 leadership changes have allowed for new opportunities to grow, innovate, and become more agile in meeting the health care needs across Washington and beyond.

Julie Akers poses in front of the Pharmaceutical and Biomedical Sciences building

Dear Friends and Colleagues,

This has been a year of extremes – both successes and challenges.

Across the University, leadership transitions and shifting financial realities have challenged us to think differently about the future of pharmacy education. In moments like this, strong institutions do more than adapt—they reimagine what is possible. That is exactly what we are doing.

Inspired by the forward-looking leadership of President Betsy Cantwell and in close partnership with Provost Chris Riley-Tillman, we have taken a hard, honest look at how our college must evolve to remain not only sustainable, but indispensable. Faculty transitions have opened the door to elevate bold new leaders, expand revenue-generating initiatives, redesign our curriculum for the rapidly expanding role of pharmacists, and strengthen enrollment to meet Washington’s critical workforce needs. Thank you to each of those listed here who have taken on new leadership roles to drive the college forward.

The results are encouraging:

Our first-time NAPLEX pass rate climbed to 92.5%, placing us as #3 on the West Coast among public pharmacy schools and #1 in the Pacific Northwest. At the same time, our PharmD applications surged to their highest level in nearly a decade—clear evidence that the next generation sees both the urgency and the opportunity in our mission.

Yet we are clear-eyed about the road ahead. Reduced federal and state support, rapid advances in artificial intelligence, and profound shifts in health care delivery are reshaping our landscape in real time. As interim dean, simply keeping the ship afloat is not an option.

This is a pivotal moment. With your continued partnership—your advocacy, collaboration, mentorship, and philanthropy—we have the opportunity to not simply respond to change, but to lead it. Thank you for being part of what comes next.

Julie Akers signature

Julie Akers (’00), Interim Dean
WSU College of Pharmacy and Pharmaceutical Sciences

Portrait of John Clarke

John Clarke

Department of Pharmaceutical Sciences Chair

Portrait of Kimberly McKeirnan

Kimberly McKeirnan

Department of Pharmacotherapy Interim Chair

Portrait of Terri Levien

Terri Levien

Associate Dean of Accreditation and Assessment

Portrait of Mary Paine

Mary Paine

Director of Industry Advancement

Megan Undeberg

Megan Undeberg

Assistant Dean of Rural Health

Portrait of Nicole Rodin

Nicole Rodin

Director of Clinical Pharmacy Operations

Advancing Pharmacy and
Research on a National Scale

Washington State Academy of Sciences Member

Sergey Tolmachev is a professor in the Department of Pharmaceutical Sciences and directs the United States Transuranium and Uranium Registries (USTUR), a federally-funded program that studies how actinide elements like plutonium and uranium behave in the human body. His membership in the Washington State Academy of Sciences represents the highest recognition of scientific and engineering excellence in the state. Elected by their peers, members are nationally distinguished leaders whose work shapes their fields and advances the public good.

National Association of Chain Drug Stores (NACDS) Foundation’s Cultivating Innovation in Care Award

Interim Dean Julie Akers was recognized for her research on the cost effectiveness of pharmacists treating minor illnesses and the pharmacist’s role in improving access to patient care amid the nation’s primary care shortage. The NACDS Foundation’s Cultivating Innovation in Care Award recognizes transformative, evidence-based research that expand patient access, improve outcomes, and advance the role of pharmacy in health care delivery.

American Society for Pharmacology and Experimental Therapeutics (ASPET) President

Kathryn Meier, a pharmaceutical sciences professor and associate dean for undergraduate programs, led the launch of the college’s undergraduate program in Pharmaceutical and Medical Sciences. She was elected president of ASPET, a leading scientific organization that advances the discovery and understanding of how drugs work in the body. ASPET sets rigorous research standards, publishes highly influential journals, and shapes drug development and regulatory science. ASPET helps translate basic pharmacology into safer, more effective therapies.
250+ Partnerships and Rotation Sites
$7.7 M in Federal Grand Funding (FY 2025)
$8.9 M in Research Funding (FY 2025)

Headline News and
Groundbreaking Research

WSU researcher pioneers new study model with clues to anti-aging

A WSU research team has opened the door to using genetically engineered mice to study human lifespan on a cellular level. Pharmaceutical Sciences Professor Jiyue Zhu, who led the team, recently published these findings in Nature Communications and is considered a major breakthrough in understanding telomeres and its relation to age-related diseases.

WSU Royalty Revenues Eclipse $19M in FY25

Standing alongside the nationally iconic Cosmic Crisp® apple, Pharmacotherapy Professor Kimberly McKeirnan’s vaccine training manual for pharmacy technicians generated record-breaking royalties for the University in 2025. Its success reflects the real-world impact of the college’s faculty expertise—advancing pharmacy practice nationwide while reinvesting in education, research, and student success.
$2.2 M in Royalties Generated for the University (FY 2025)
92.5% NAPLEX First-Time Pass Rate

#1 in the Pacific Northwest and #3 among West Coast public pharmacy schools

86% 2025 Residency Match Rate

Meeting our Land-Grant Mission

… to promote the liberal and practical education of the industrial classes in the several pursuits and professions in life.

Morrill Act 1862

Areas where graduates were placed with ASHP residencies

includes PGY1, PGY2 and PGY1+2

5 Rural Health Initiative Graduates

Residencies with Funding Support from the College

  • Yakima Valley Farm Workers Clinic (Toppenish)
  • Yakima Valley Farm Workers Clinic (Spokane)
  • Centralia Pharmacy (Centralia)
  • Goldendale Pharmacy (Goldendale)
  • Tim’s Pharmacy (Yelm)
  • Two Providence Medical Group Psychiatric Pharmacy (Spokane)

Clinical Residencies Areas of Expertise

  • Oncology
  • Hospital Administration
  • Managed Care
  • Infectious Diseases
  • Ambulatory Care
  • Community
  • Behavioral Health

Pharmacy group

Donor Support in Action

85 Incoming PharmD students enrolled thanks to competitive recruitment scholarships.
6 Yakima class of 2029 pharmacy students pose for a group photo during their orientation
Class of 2029 pharmacy students on the Yakima campus
Pharmacy students gather in Olympia for Legislative Day
60+ State representative offices met with students on Legislative Day in Olympia.
#3 Donor-funded NAPLEX review propelled class of 2025 to third place in NAPLEX pass rates among West Coast public pharmacy schools.
class of 2025 group white coat photo
Portrait of Victoria Nuon

You didn’t just fund an education. You lifted an entire generation.

Victoria Nuon, class of 2027

How to Support our College

Save the Date!

Join us for another memorable evening to celebrate our wonderful community of alumni, donors, faculty, and students. Proceeds will benefit student success.